Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.81+0.03 (+0.63%)
Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%
Lifevantage revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Lifevantage's revenue for the twelve months ending Jun 30, 2026 was $182.59M, down 20.1% year over year. For fiscal 2026 it was $182.59M, down 20.1% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $232.92M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $182.59M | -20.1% |
| FY2025 | Jun 30, 2025 | $228.53M | +14.2% |
| FY2024 | Jun 30, 2024 | $200.16M | -6.2% |
| FY2023 | Jun 30, 2023 | $213.40M | +3.4% |
| FY2022 | Jun 30, 2022 | $206.36M | -6.3% |
| FY2021 | Jun 30, 2021 | $220.18M | -5.5% |
| FY2020 | Jun 30, 2020 | $232.92M | +3.1% |
| FY2019 | Jun 30, 2019 | $225.96M | +11.2% |
| FY2018 | Jun 30, 2018 | $203.20M | +1.9% |
| FY2017 | Jun 30, 2017 | $199.49M | -3.4% |
| FY2016 | Jun 30, 2016 | $206.54M | +8.5% |
| FY2015 | Jun 30, 2015 | $190.34M | -11.0% |
| FY2014 | Jun 30, 2014 | $213.97M | +2.8% |
| FY2013 | Jun 30, 2013 | $208.18M | +65.0% |
| FY2012 | Jun 30, 2012 | $126.18M | +224.2% |
| FY2011 | Jun 30, 2011 | $38.92M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $42.38M | -23.1% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $43.72M | -25.2% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $48.93M | -27.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $47.56M | +0.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $55.11M | +12.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $58.44M | +21.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $67.76M | +31.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $47.21M | -8.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $48.93M | -9.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $48.25M | -10.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $51.62M | -3.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $51.36M | -0.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $54.22M | +6.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $53.74M | +7.5% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $53.66M | +2.8% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $51.77M | -2.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $50.94M | -7.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $50.00M | -3.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $52.19M | -11.6% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $53.22M | -2.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $54.78M | -7.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $51.57M | -8.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $59.01M | -3.6% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $54.83M | -2.5% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $59.37M | +5.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $56.08M | +0.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $61.24M | +5.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $56.23M | +1.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $56.17M | +4.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $56.01M | +10.8% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $58.17M | +17.6% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $55.61M | +13.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $54.03M | +6.7% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $50.56M | +12.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $49.48M | +1.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $49.13M | -10.5% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $50.64M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $45.01M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $48.95M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $54.89M | – |
See a number that looks wrong?